##plugins.themes.bootstrap3.article.main##

Up to 10% of all pregnancies in the US are complicated by diabetes. Among them, 0.2 to 0.5 % of the individuals had type 1 diabetes (T1DM). Preterm birth, preeclampsia, macrosomia, shoulder dystocia, intrauterine fetal death, fetal growth restriction, cardiac and renal abnormalities, as well as uncommon neural disorders including sacral agenesis, are all heightened risks for pregnancies affected by T1DM. It has been demonstrated that preconception planning and intensive glycemic control can lower the rate of fetal loss and abnormalities in pregnancies complicated by T1DM. The number of alternatives available to the obstetric team has risen as a result of recent improvements in insulin formulations and delivery techniques. To promote compliance and guarantee optimal glucose control, insulin regimens should be customized for each patient. For effective care, intensive preconception counseling with regular follow-up visits that emphasize strict glucose control is advised.

Downloads

Download data is not yet available.

References

  1. International Diabetes Federational. IDF Atlas. 8th Edition 2017. [Internet] 2017 [cited 2019 June 19] Available from: https://diabetesatlas.org/resources/2017-atlas.html.
     Google Scholar
  2. Morrison M, Hendrieckx C, Nankervis A, Audehm R, Farrell K, Houvardsa E, et al. Factors associated with attendance for pre-pregnancy care and reasons for non-attendance among women with diabetes. Diabetes Res Clin Pract. 2018; 142: 269-275.
    DOI  |   Google Scholar
  3. Miko E, Csaszar A, Bodis J, Kovacs K. The Maternal-Fetal Gut Microbiota Axis: Physiological Changes, Dietary Influence, and Modulation Possibilities. Life (Basel). 2022; 12(3): 424.
    DOI  |   Google Scholar
  4. Murphy HR, Howgate C, O'Keefe J, Myers J, Morgan M, Coleman MA, et al. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 2021; 9(3): 153-164.
    DOI  |   Google Scholar
  5. Hart BN, Shubrook JH, Mason T. Pregestational Diabetes and Family Planning. Clin Diabetes. 2021; 39(3): 323-328.
    DOI  |   Google Scholar
  6. Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Damm P, Mathiesen ER. Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabet Med. 2012; 29(5): 558-566.
    DOI  |   Google Scholar
  7. Mallika P, Tan A, SA, TA, Alwi SS, Intan G. Diabetic retinopathy, and the effect of pregnancy. Malays Fam Physician. 2010; 5(1): 2-5.
     Google Scholar
  8. Kalra B, Gupta Y, Kalra S. Pre-conception management of diabetes. J Pak Med Assoc. 2015; 65(11): 1242-1243.
     Google Scholar
  9. Higgins M, Galvin D, McAuliffe F, Coffey M, Fifth R, Daly S, et al. pregnancy in women with Type 1 and Type 2 diabetes in Dublin. Ir J Med Sci. 2011; 180(2): 469-473.
    DOI  |   Google Scholar
  10. Piccoli GB, Clari R, Ghiotto S, Castelluccia N, Colombi N, Mauro G, et al. Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study. Rev Diabet Stud. 2013; 10(1): 6-26.
    DOI  |   Google Scholar
  11. Buhary BM, Almohareb O, Aljohani N, Alzahrani SH, Elkaissi S, Sherbeeni S, et al. Glycemic control and pregnancy outcomes in patients with diabetes in pregnancy: A retrospective study. Indian J Endocrinol Metab. 2016; 20(4): 481-490.
    DOI  |   Google Scholar
  12. Wahabi HA, Fayed A, Esmaeil S, Elmorshedy H, Titi MA, Amer YS, et al. Systematic review, and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes. PLoS One. 2020; 15(8): e0237571.
    DOI  |   Google Scholar
  13. Wright LA, Hirsch IB. Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters. Diabetes Technol Ther. 2017; 19(S2): S16-S26.
    DOI  |   Google Scholar
  14. Immanuel J, Simmons D. A Perspective on the Accuracy of Blood Glucose Meters During Pregnancy. Diabetes Care. 2018; 41(10): 2053-2058.
    DOI  |   Google Scholar
  15. Yamamoto JM, Corcoy R, Donovan LE, Stewart ZA, Tomlinson G, Beardsall K, et al. Maternal glycaemic control, and risk of neonatal hypoglycaemia in Type 1 diabetes pregnancy: a secondary analysis of the CONCEPTT trial. Diabet Med. 2019; 36(8): 1046-1053.
    DOI  |   Google Scholar
  16. Middleton P, Crowther CA, Simmonds L. Different intensities of glycaemic control for pregnant women with pre-existing diabetes. Cochrane Database Syst Rev. 2016; 2016(5): CD008540.
    DOI  |   Google Scholar
  17. Pease A, Zomer E, Liew D, Lo C, Earnest A, Zoungas S. Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesis. Syst Rev. 2020; 9(1): 171.
    DOI  |   Google Scholar
  18. Li A, Brackenridge A. The role of continuous glucose monitoring in pregnancy. Obstet Med. 2022; 15(1): 6-10.
    DOI  |   Google Scholar
  19. Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomized controlled trial. Lancet. 2017; 390(10110): 2347-2359.
    DOI  |   Google Scholar
  20. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016; 388(10057): 2254-2263.
    DOI  |   Google Scholar
  21. McCance DR, Holmes VA, Maresh MJ, Patterson CC, Walker JD, Pearson DW, et al. Vitamins C and E for prevention of preeclampsia in women with type 1 diabetes (DAPIT): a randomized placebo-controlled trial. Lancet. 2010; 376(9737): 259-266.
    DOI  |   Google Scholar


Most read articles by the same author(s)

1 2 3 > >>